
Mizuho Medy Co Ltd
TSE:4595

Mizuho Medy Co Ltd
Treasury Stock
Mizuho Medy Co Ltd
Treasury Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Treasury Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mizuho Medy Co Ltd
TSE:4595
|
Treasury Stock
-ÂĄ2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
![]() |
Terumo Corp
TSE:4543
|
Treasury Stock
-ÂĄ41.8B
|
CAGR 3-Years
-88%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-104%
|
|
![]() |
Olympus Corp
TSE:7733
|
Treasury Stock
-ÂĄ123.4B
|
CAGR 3-Years
-92%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-60%
|
|
![]() |
Sysmex Corp
TSE:6869
|
Treasury Stock
-ÂĄ12.3B
|
CAGR 3-Years
-241%
|
CAGR 5-Years
-110%
|
CAGR 10-Years
-46%
|
|
![]() |
Nihon Kohden Corp
TSE:6849
|
Treasury Stock
-ÂĄ10.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-17%
|
|
![]() |
JEOL Ltd
TSE:6951
|
Treasury Stock
-ÂĄ688m
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-3%
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

See Also
What is Mizuho Medy Co Ltd's Treasury Stock?
Treasury Stock
-2m
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Treasury Stock amounts to -2m JPY.
What is Mizuho Medy Co Ltd's Treasury Stock growth rate?
Treasury Stock CAGR 5Y
-5%
Over the last year, the Treasury Stock growth was 6%. The average annual Treasury Stock growth rates for Mizuho Medy Co Ltd have been -3% over the past three years , -5% over the past five years .